Empresa Auris Medical Holding Ltd Nasdaq
Acciones
BMG070251027
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/11/21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/06/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/03/18 |
Mats Blom
BRD | Director/Board Member | 59 | 01/04/17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 240 245 | 2 220 245 ( 99,11 %) | 0 | 99,11 % |
Información de la empresa
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+18,34 % | 124 mil M | |
+15,06 % | 109 mil M | |
-6,39 % | 23,84 mil M | |
+0,99 % | 22,42 mil M | |
-14,87 % | 17,5 mil M | |
-41,64 % | 16,43 mil M | |
-12,07 % | 16,61 mil M | |
+1,05 % | 13,4 mil M | |
+25,87 % | 11,47 mil M |